title: Conclusions about the quadrivalent human papillomavirus vaccine efficacy based on alternate dosing schedules and less than three dose immunogenicity is inappropriate.
authors: Rowntree Endowed Chair and Professor of Family and Geriatric Medicine and Obstetrics and Gynecology, Epidemiology and Population Health and Health Promotion and Behavioral Sciences, University of Louisville Schools of Medicine and Public Health.
authors: Diane M
authors: DM
authors: Harper
mesh_terms: D052685:Alphapapillomavirus / Q000276:immunology*; D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000276:immunology*
chemical_list: D053918:Papillomavirus Vaccines